Author

Sushmita Bhowmick

Bhairab Ganguly CollegeORCID 0000-0002-4835-8875Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 3 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Organism:human· 3 Approach:statistical model· 3 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Souvik ChakrabortyiD· 4 shared Tarasankar MaitiiD· 3 shared Deepanjan SarkariD· 1 shared Sajal Kumar DeyiD· 1 shared Soumili SarkariD· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

5 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersNeuroscience

Souvik ChakrabortyORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Identifying potential dopamine receptor D2 antagonist from Rauwolfia serpentina An in-silico virtual screening approach

Souvik Chakraborty, Sushmita Bhowmick, Tarasankar Maiti

This study identifies potential dopamine receptor D2 antagonists from Rauwolfia serpentina using in-silico virtual screening and ADMET analysis.

bioRxiv · Oct 10, 2024 · PreprintPharmacology & Toxicology

Identifying common genes, proteins, and pathways from human miRNA and gene blood profiles in multiple sclerosis patients.

Souvik Chakraborty, Tarasankar Maiti, Sushmita Bhowmick, Soumili Sarkar

The paper identifies hub genes and pathways associated with multiple sclerosis using blood-based gene and miRNA profiles from public datasets.

bioRxiv · Nov 29, 2022 · PreprintNeuroscience

Identifying potential key genes and existing drugs for Multiple sclerosis, Schizophrenia, and Autism- an in silico approach

Sajal Kumar Dey, Sushmita Bhowmick, Souvik Chakraborty

This study identifies 15 key genes and 37 FDA-approved drugs potentially relevant to Multiple sclerosis, Schizophrenia, and Autism using bioinformatics tools and drug-gene interaction analysis.

bioRxiv · Nov 30, 2021 · PreprintNeuroscience

In-silico analysis: common biomarkers of NDs

Deepanjan Sarkar, Souvik Chakraborty, Sushmita Bhowmick, Tarasankar Maiti

The paper identifies common differentially expressed genes across neurodegenerative disorders and suggests they may serve as potential biomarkers.

bioRxiv · Sep 25, 2021 · PreprintNeuroscience